Immunohistochemical study on the nm23 gene produce (NDP kinase) in oral squamous cell carcinoma
- PMID: 9307712
- DOI: 10.1016/s0964-1955(97)00020-1
Immunohistochemical study on the nm23 gene produce (NDP kinase) in oral squamous cell carcinoma
Abstract
The nm23 gene is a potential metastasis suppressor gene originally identified using a murine melanoma cell line. Immunohistochemical investigation on the role of nm23 gene product (nucleoside diphosphate kinase: NDPK) in squamous cell carcinomas of the oral cavity was performed and compared to clinical and histopathological factors. The stainability of NDPK did not correlate to tumour extent, differentiation and mode of invasion. However, the NDPK positive group tended to have a lower frequency of lymph node metastasis, and a better prognosis than the NDPK negative group. Consequently, nm23/NDPK is suggested to be a metastasis suppressor factor that may be useful for predicting tumour metastasis and prognosis in oral squamous cell carcinoma.
Similar articles
-
Immunohistochemical analysis of nucleoside diphosphate kinases in oral squamous cell carcinomas.Oncology. 1997 Jan-Feb;54(1):63-8. doi: 10.1159/000227663. Oncology. 1997. PMID: 8978595
-
[The regulation of nm23-H1/NDPK-A in different processes of regional lymph node metastases of oral squamous cell carcinomas].Hua Xi Kou Qiang Yi Xue Za Zhi. 2003 Aug;21(4):263-6. Hua Xi Kou Qiang Yi Xue Za Zhi. 2003. PMID: 14513578 Chinese.
-
Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.Clin Cancer Res. 1999 Dec;5(12):4301-7. Clin Cancer Res. 1999. PMID: 10632374
-
Nm23/nucleoside diphosphate kinase in human cancers.J Bioenerg Biomembr. 2000 Jun;32(3):301-8. doi: 10.1023/a:1005597231776. J Bioenerg Biomembr. 2000. PMID: 11768314 Review.
-
[Nucleoside diphosphate kinase/Nm23 and metastatic potency].Bull Cancer. 1993 Aug;80(8):717-22. Bull Cancer. 1993. PMID: 8204954 Review. French.
Cited by
-
nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression.Am J Pathol. 2001 May;158(5):1785-91. doi: 10.1016/S0002-9440(10)64134-X. Am J Pathol. 2001. PMID: 11337376 Free PMC article.
-
Identification of tetranectin as a potential biomarker for metastatic oral cancer.Int J Mol Sci. 2010 Sep 2;11(9):3106-21. doi: 10.3390/ijms11093106. Int J Mol Sci. 2010. PMID: 20957082 Free PMC article.
-
nm23 protein expression in metastatic and non-metastatic tongue squamous cell carcinoma.Braz J Otorhinolaryngol. 2008 May-Jun;74(3):356-9. doi: 10.1016/s1808-8694(15)30568-1. Braz J Otorhinolaryngol. 2008. PMID: 18661008 Free PMC article.
-
NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.Lab Invest. 2018 Feb;98(2):219-227. doi: 10.1038/labinvest.2017.105. Epub 2017 Oct 9. Lab Invest. 2018. PMID: 28991262
-
Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma.Br J Cancer. 2004 Jun 1;90(11):2186-93. doi: 10.1038/sj.bjc.6601808. Br J Cancer. 2004. PMID: 15150613 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials